These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

170 related items for PubMed ID: 7069227

  • 41.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 42. The vaccine candidate Vibrio cholerae 638 is protective against cholera in healthy volunteers.
    García L, Jidy MD, García H, Rodríguez BL, Fernández R, Año G, Cedré B, Valmaseda T, Suzarte E, Ramírez M, Pino Y, Campos J, Menéndez J, Valera R, González D, González I, Pérez O, Serrano T, Lastre M, Miralles F, Del Campo J, Maestre JL, Pérez JL, Talavera A, Pérez A, Marrero K, Ledón T, Fando R.
    Infect Immun; 2005 May; 73(5):3018-24. PubMed ID: 15845509
    [Abstract] [Full Text] [Related]

  • 43. Titration of cholera antitoxin in human sera by microhemagglutination with formalinized erythrocytes.
    Hochstein HD, Feeley JC, DeWitt WE.
    Appl Microbiol; 1970 May; 19(5):742-5. PubMed ID: 5463574
    [Abstract] [Full Text] [Related]

  • 44.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49. Clinical and immunologic characteristics of Vibrio cholerae O139 Bengal infection in North American volunteers.
    Morris JG, Losonsky GE, Johnson JA, Tacket CO, Nataro JP, Panigrahi P, Levin MM.
    J Infect Dis; 1995 Apr; 171(4):903-8. PubMed ID: 7706818
    [Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52. [Choleragen-anatoxin chemical cholera vaccine enriched with Ogawa O-antigen].
    Dzhaparidze MN, Nikitina GP, Kulikova VL, Popov AA, Naumov AV.
    Zh Mikrobiol Epidemiol Immunobiol; 1984 Apr; (4):70-4. PubMed ID: 6204471
    [Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54. Dried Blood Spots for Measuring Vibrio cholerae-specific Immune Responses.
    Iyer AS, Azman AS, Bouhenia M, Deng LO, Anderson CP, Graves M, Kováč P, Xu P, Ryan ET, Harris JB, Sack DA, Luquero FJ, Leung DT.
    PLoS Negl Trop Dis; 2018 Jan; 12(1):e0006196. PubMed ID: 29377882
    [Abstract] [Full Text] [Related]

  • 55. A semi-automated vibriocidal assay for improved measurement of cholera vaccine-induced immune responses.
    Yang JS, Kim HJ, Yun CH, Kang SS, Im J, Kim HS, Han SH.
    J Microbiol Methods; 2007 Nov; 71(2):141-6. PubMed ID: 17888533
    [Abstract] [Full Text] [Related]

  • 56. Immunogenicity of Vibrio cholerae ghosts following intraperitoneal immunization of mice.
    Eko FO, Hensel A, Bunka S, Lubitz W.
    Vaccine; 1994 Nov; 12(14):1330-4. PubMed ID: 7856300
    [Abstract] [Full Text] [Related]

  • 57. [The properties of the Vibrio cholerae strains isolated in large districts in western Dagestan in 1994].
    Cherepakhina IIa, Lomov IuM, Karagozova AV, Pomukhina OI, Smolikova LM, Makedonova LD, Dimitrova NI, Nekliaev VN, Balakhnova VV, Chirkova OO.
    Zh Mikrobiol Epidemiol Immunobiol; 1995 Nov; Suppl 2():84-6. PubMed ID: 7771155
    [Abstract] [Full Text] [Related]

  • 58. Vibriocidal titre in cholera cases and contacts: its value in assessing endemicity of or susceptibility to cholera.
    Khan MU, Barua DK, Begum T, Shahidullah M.
    Trop Geogr Med; 1987 Jul; 39(3):271-5. PubMed ID: 3433343
    [Abstract] [Full Text] [Related]

  • 59.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 60.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.